BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging &amp; Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The European School of Multimodality Imaging &amp; Therapy (ESMIT)
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging &amp; Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250425T000000
DTEND;TZID=Europe/Vienna:20260425T235959
DTSTAMP:20260421T203216
CREATED:20250225T141140Z
LAST-MODIFIED:20250605T144111Z
UID:2257-1745539200-1777161599@esmit.eanm.org
SUMMARY:Highlights of Focus Meeting 6: Shaping the Future of Breast Cancer Care with Molecular Imaging
DESCRIPTION:Breast cancer remains the most frequently diagnosed cancer and the leading cause of cancer-related death in women worldwide. Despite significant advancements in imaging and treatment\, clinical practice remains heterogeneous across institutions and disciplines. Molecular imaging has a pivotal role in breast cancer care\, from diagnosis to recurrence assessment. To address these discrepancies and define the future direction of imaging in breast cancer\, the European Association of Nuclear Medicine (EANM) devoted its 6th Focus Meeting to this topic\, under the following motto “Shaping the Future of Breast Cancer Care with Molecular Imaging”. \n\n\n\n \n\n\n\nThe aims of this project were: \n\n\n\n\nTo define the role of imaging in breast cancer\, particularly the utility of nuclear medicine techniques in different clinical settings (including initial systemic staging\, assessment of response to therapy\, and detection of recurrence). \n\n\n\nTo reach a multidisciplinary consensus on the current state of the art in nuclear medicine imaging in breast cancer.\n\n\n\nTo generate expert recommendations on how best to guide professionals in their clinical decisions\, beyond the existing guidelines. \n\n\n\nTo identify knowledge gaps and topics with lack of scientific evidence for potential future studies.\n\n\n\n\n \n\n\n\n \n\n\n\nThe recordings in this course are sponsored by Novartis. \n\n\n\n\n\n\n\n\n\nRegister nowEnrol in the online course now for free! Register now\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\n\nIsabel T. RubioSpeaker \n\n\n\n\n\nFrederique Penault LlorcaSpeaker \n\n\n\n\n\nThiemo van NijnattenSpeaker \n\n\n\n\n\nElizabeth DibbleSpeaker \n\n\n\n\n\nTessa BuckleSpeaker \n\n\n\n\n\nKatja Pinker DomenigSpeaker \n\n\n\n\n\n\n\n\n\nSofia Carrilho-VazSpeaker \n\n\n\n\n\nMartina Bašić-KoretićSpeaker \n\n\n\n\n\nDavid GroheuxSpeaker \n\n\n\n\n\nGary UlanerSpeaker \n\n\n\n\n\nGeraldine GebhartSpeaker \n\n\n\n\n\nWolfgang WeberSpeaker \n\n\n\n\n\n\n\n\n\nValeria RomeoSpeaker \n\n\n\n\n\nAlessandra GennariSpeaker \n\n\n\n\n\nKarolien GoffinSpeaker \n\n\n\n\n\nNadia HarbeckSpeaker \n\n\n\n\n\nPascal BaltzerSpeaker \n\n\n\n\n\nMichel van KruchtenSpeaker \n\n\n\n\n\n\n\n\n\nGary Cook Speaker \n\n\n\n\n\nPaola Anna ErbaSpeaker \n\n\n\n\n\nJoana M RibeiroSpeaker \n\n\n\n\n\nCarolien SchröderSpeaker \n\n\n\n\n\nRitse MannSpeaker \n\n\n\n\n\nPhilipp BackhausSpeaker \n\n\n\n\n\n\n\n\n\nMalene Gubbe Hildebrand Speaker \n\n\n\n\n\nFatima CardosoSpeaker \n\n\n\n\n\nAntoinette AttardSpeaker \n\n\n\n\n\nFrancesco SchnettiniSpeaker \n\n\n\n\n\nSofia RiveraSpeaker \n\n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/highlights-of-focus-meeting-6-shaping-the-future-of-breast-cancer-care-with-molecular-imaging/
LOCATION:Online
CATEGORIES:Clinical Nuclear Medicine,Self-paced Online Course
ORGANIZER;CN="ESMIT":MAILTO:esmit@eanm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250919T133000
DTEND;TZID=Europe/Vienna:20250919T143000
DTSTAMP:20260421T203216
CREATED:20250225T110337Z
LAST-MODIFIED:20250911T085022Z
UID:2253-1758288600-1758292200@esmit.eanm.org
SUMMARY:Radiation Safety for Oncological Patients before and after Nuclear Medicine Procedures and Radiation Safety of Nursing Staff
DESCRIPTION:This webinar will emphasize the critical importance of radiation protection in safeguarding both the occupational health of care providers and the well-being of patients undergoing radionuclide therapy. \n\n\n\nIt will underscore the necessity of adhering to established guidelines and protocols when handling radioactive materials to ensure safety and treatment efficacy. \n\n\n\nFurthermore\, the session will explore the role of interprofessional collaboration and continuing education among health care providers in enhancing radiation safety practices. It will also present evidence-based strategies to mitigate patients’ symptoms associated with the adverse effects of radionuclide treatment. \n\n\n\n\n\n\n\n \n\n\n\nRegister now!Enrol in the live webinar now for free! Register now\n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nTo identify the primary steps for introducing newly hired health care staff to radionuclide therapy protocols and recognize the importance of continuous education in maintaining adherence to institutional safety and procedural standards.\n\n\n\nTo evaluate various educational methods and strategies used to train health care providers—including nurses\, caregivers\, seasonal workers\, and clinical assistants—in the principles\, procedures\, and safety protocols of radionuclide therapy.\n\n\n\nTo demonstrate effective patient education techniques and symptom management strategies for individuals undergoing radionuclide therapy\, with attention to minimizing adverse effects and enhancing patient comprehension.\n\n\n\nTo compare different radiation safety protocols and clinical guidelines associated with Lutathera and radioiodine therapies\, with respect to implications for both patients and health care providers.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n \n\n\n\nAll health care providers involved in the care of oncological patients undergoing radionuclide treatment in clinical practice \n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n \n\n\n\n\n\nLace MatarloSpeaker \n\n\n\n\n\nMatthias Hellberg-NaegeleModerator \n\n\n\n\n\nSigrid Leide SvegbornSpeaker
URL:https://esmit.eanm.org/event/radiation-safety-for-oncological-patients-before-and-after-nuclear-medicine-procedures-and-radiation-safety-of-nursing-staff/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
END:VCALENDAR